Ceruloplasmin/Transferrin Ratio Changes in Alzheimer's Disease
Author(s) -
Rosanna Squitti,
Carlo Salustri,
Mariacristina Siotto,
Mariacarla Ventriglia,
Fabrizio Vernieri,
Domenico Lupoi,
Emanuele Cassetta,
Paolo Maria Rossini
Publication year - 2010
Publication title -
international journal of alzheimer s disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.657
H-Index - 49
eISSN - 2090-8024
pISSN - 2090-0252
DOI - 10.4061/2011/231595
Subject(s) - ceruloplasmin , transferrin , transferrin saturation , medicine , chemistry , endocrinology , alzheimer's disease , serum iron , atrophy , biochemistry , iron deficiency , anemia , disease
The link between iron and Alzheimer's disease (AD) has been mainly investigated with a focus on the local accumulation of this metal in specific areas of the brain that are critical for AD. In the present study, we have instead looked at systemic variations of markers of iron metabolism. We measured serum levels of iron, ceruloplasmin, and transferrin and calculated the transferrin saturation and the ceruloplasmin to transferrin ratio (Cp/Tf). Cp/Tf and transferrin saturation increased in AD patients. Cp/Tf ratios also correlated positively with peroxide levels and negatively with serum iron concentrations. Elevated values of ceruloplasmin, peroxides, and Cp/Tf inversely correlated with MMSE scores. Isolated medial temporal lobe atrophy positively correlated with Cp/Tf and negatively with serum iron. All these findings indicate that the local iron accumulation found in brain areas critical for AD should be viewed in the frame of iron systemic alterations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom